While many fast-growing stocks have struggled price-wise in the back half of 2021, most have maintained rapid business growth anyway and that will likely lead to continued success over many years and eventual stock-price recovery. Helping in that recovery is if these companies can develop into market leaders.
Both Coupang (NYSE: CPNG) and Doximity (NYSE: DOCS) have generated solid growth this year while dominating their respective industries. And yet shares of both stocks are down more than 40% off all-time highs set earlier this year. Now might be a nice buying opportunity to add these two dominant businesses to your portfolio. Let's take a closer look at the reasons why.
Image source: Getty Images.
For further details see:
2 Unstoppable Growth Stocks To Buy for 2022